A P hase II Study of G em citabine M onotherapy in B reast C ancer Patients R efractory to A nthracycline and T axane

[1]  A. Seidman.  The Evolving Role of Gemcitabine in the Management of Breast Cancer , 2001, Oncology.

[2]  G. Hortobagyi,et al.  Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. , 2001, The oncologist.

[3]  K. Possinger,et al.  Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer. , 1999, Anti-cancer drugs.

[4]  C. Vogel,et al.  Monotherapy of metastatic breast cancer: a review of newer agents. , 1999, The oncologist.

[5]  G. Hortobagyi,et al.  Treatment of breast cancer. , 1998, The New England journal of medicine.

[6]  J. Carmichael,et al.  The role of gemcitabine in the treatment of other tumours. , 1998, British Journal of Cancer.

[7]  M. Blackstein,et al.  Phase II study of gemcltablne in patients with metastatic breast cancer , 1997 .

[8]  D. Khayat,et al.  Docetaxel in combination chemotherapy for metastatic breast cancer. , 1997, Seminars in oncology.

[9]  W. Plunkett,et al.  Gemcitabine: preclinical pharmacology and mechanisms of action. , 1996, Seminars in oncology.

[10]  G. Hortobagyi,et al.  Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  V. Valero,et al.  Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Harris,et al.  Advanced breast cancer: a phase II trial with gemcitabine. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  L. Hertel,et al.  Action of 2',2'-difluorodeoxycytidine on DNA synthesis. , 1991, Cancer research.

[14]  L. Hertel,et al.  Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine). , 1990, Cancer research.

[15]  Carbone Pp,et al.  Medical treatment for advanced breast cancer. , 1978 .

[16]  N. Wolmark,et al.  Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. , 1975, Surgery, gynecology & obstetrics.